The Pharma Data

NOVEMBER 9, 2020

Merck and Eisai are committed to working together to continue to explore the potential of the KEYTRUDA plus LENVIMA combination, particularly in areas of great unmet need such as renal cell carcinoma.”. “We It is very clear that in this study, the addition of ipilimumab did not add clinical benefit but did add toxicity.

Research Laboratories 52

Research Laboratories Laboratories Treatment Therapies 52

Conversations in Drug Development Trends

DECEMBER 12, 2022

What is the difference between a Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory vs a research laboratory? The Centers for Medicare & Medicaid Services (CMS) regulates all clinical laboratory testing performed on human samples in the US through CLIA.

Clinical Trials 52

Clinical Trials Trials Laboratories Research Laboratories 52

The Pharma Data

JANUARY 21, 2021

The findings from the National Institutes of Health-supported prevention study, which enrolled nearly 1,100 participants, are significant given that until now a monoclonal antibody had not been shown to help prevent infection from COVID-19 in a late-stage trial.

Nurses 52

Nurses Research Laboratories Laboratories Virus 52

The Pharma Data

SEPTEMBER 21, 2020

“These new data from our LEAP clinical program show encouraging activity across several aggressive cancer types and expand our knowledge about the potential of KEYTRUDA plus LENVIMA to help a range of patients with these cancers,” said Scot Ebbinghaus, vice president, Clinical Research, Merck Research Laboratories.

Research Laboratories 52

Research Laboratories Laboratories Trials Therapies 52

The Pharma Data

SEPTEMBER 11, 2020

The condition “is difficult to treat and the underlying drivers and natural history of the disease are not fully established,” noted Professor Claus Bachert, head of the Department of Oto-Rhino-Laryngology and chair of the Upper Airway Research Laboratory, University Hospital Ghent, Belgium, the principal investigator of the trial.

Research Laboratories 52

Research Laboratories Laboratories Treatment Hospitals 52

Codon

OCTOBER 3, 2023

.” Can a bit of money, combined with lots of time and thoughtful community-building, foster an entire generation of writers who seed ideas, push scientific fields in new directions, or build the companies, non-profits, and research laboratories that will lead us into the future? We think so.

Research Laboratories 86

Research Laboratories Science Laboratories International 86

Broad Institute

OCTOBER 17, 2023

That interest in science led her to a weekend science course and a field trip to a plant research laboratory, where she saw scientists hybridizing roses and genetically modifying tomatoes. As she drew arrows connecting the evaporation, condensation, and precipitation phases, she thought, “This makes sense to me.

Research 98

Research Small Molecule Science Disease 98

The Strateos Blog: Drug Discovery

DECEMBER 13, 2021

AUTOMATION CAN OVERCOME BOTTLENECKS IN SYNTHETIC BIOLOGY PIPELINES Daniels’ talk entitled Accelerating Riboswitch Engineering for the Development of Human Performance Biosensors outlines a recent client collaboration with the Air Force Research Laboratory (AFRL) where Strateos’ automated cloud lab was leveraged to accelerate rational (..)

Engineering 52

Engineering Protein Expression Research Laboratories RNA 52

PerkinElmer

MAY 28, 2020

The handling of these pathogens needs to take place in research laboratories that are designated as biosafety level 3 or higher due to its dangerous infectious nature. Unfortunately, the road towards treatment can be time-consuming, especially when utilizing assays with live virus.

Vaccine 52

Vaccine Disease Virus Small Molecule 52

The Pharma Data

NOVEMBER 19, 2020

Patel currently serves as the director of Infectious Diseases Research Laboratory at the Mayo Clinic, as well as co-director of the clinical Bacteriology Laboratory. Prior to FDNA, Gelbman served as a corporate and transactional attorney in Israel as well as the United States.

Laboratories 52

Laboratories Research Laboratories Science Organic Chemistry 52

The Pharma Data

AUGUST 31, 2021

“While the treatment landscape has evolved, an unmet need remains for appropriate patients newly diagnosed with certain types of advanced urothelial carcinoma who are not eligible for platinum-containing chemotherapy,” said Dr. Scot Ebbinghaus, vice president, clinical research, Merck Research Laboratories. “We

FDA Approval 52

FDA Approval Treatment FDA Research Laboratories 52

The Pharma Data

JULY 12, 2021

“It continues to be critically important to advance potential antiviral treatments to address the devastating impact of COVID-19 globally,” said Dr. Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. “If

Clinical Trials 52

Clinical Trials Laboratories Research Laboratories RNA 52

The Pharma Data

MARCH 8, 2021

“We continue to make progress in our Phase 2/3 clinical programs evaluating molnupiravir in both outpatient and hospital settings and plan to provide updates when appropriate,” said Dr. Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. About Molnupiravir.

Trials 69

Trials Virus RNA Research Laboratories 69

The Pharma Data

JULY 29, 2021

About Loxo Oncology at Lilly Loxo Oncology at Lilly was created in December 2019, combining the Lilly Research Laboratories oncology organization and Loxo Oncology, which was acquired by Lilly in early 2019. For more information, please visit www.kumquatbiosciences.com.

Small Molecule 52

Small Molecule Immune Response Research Laboratories Laboratories 52

Drug Target Review

NOVEMBER 1, 2023

Another key difference with industry is the close partnership with the Royal Marsden Hospital, the first hospital in the world dedicated to cancer diagnosis, treatment, research and education. Both of the ICR’s research laboratory sites in Sutton and in Chelsea are in close proximity to the Royal Marsden Hospital sites.

Fragment Screening 96

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays 96

KIF1A

MAY 24, 2023

A New Opportunity: the KIF1A Research Network in Action KIF1A.ORG was presented with such an opportunity by teaming up with Dr. Rebecca Shi of Stanford University, who worked to create a research laboratory course for undergraduates in the Stanford Biology department for the Spring 2023 semester.

Disease 98

Disease Laboratories Research Science 98

The Pharma Data

JUNE 7, 2023

We are delighted that PREVYMIS is now approved to help prevent CMV disease in adult kidney transplant patients at high risk,” said Dr. Elizabeth Rhee, vice president, global clinical development, Merck Research Laboratories. “At Source link: [link]

FDA Approval 40

FDA Approval FDA Disease Research Laboratories 40

The Pharma Data

OCTOBER 12, 2021

The winning research receives 5,000 USD and a bronze horse for the research that has the highest translational potential; the investigator is awarded with 1,000 USD and the research laboratory 4,000 USD to continue the great work. This year, Prof.

Research Laboratories 52

Research Laboratories Laboratories Therapies Production 52

The Pharma Data

DECEMBER 23, 2020

I think we have to be aware about that,” said study author Jude Mary Cenat, director of the Vulnerability, Trauma, Resilience and Culture Research Laboratory at the University of Ottawa in Canada.

Research Laboratories 52

Research Laboratories Laboratories Research 52

Codon

DECEMBER 10, 2023

If you have protein libraries in your research laboratory, please send them to us (datasets@alignbio.org) for analysis. The biggest challenge will be to acquire DNA that encodes millions of different proteins. Synthesizing that much DNA is cost-prohibitive. We’ll analyze the proteins and provide you with expression data for free.

Protein Expression 114

Protein Expression Laboratories DNA Engineering 114

The Pharma Data

MARCH 16, 2021

The Lieber Institute for Brain Development/Maltz Research Laboratories was established in 2010 to plot a new course in biomedical research that would improve the lives of individuals affected with developmental brain disorders. The Lieber Institute for Brain Development.

Licensing 52

Licensing Licensing Research Laboratories Treatment 52

Codon

OCTOBER 3, 2023

.” Can a bit of money, combined with lots of time and thoughtful community-building, foster an entire generation of writers who seed ideas, push scientific fields in new directions, or build the companies, non-profits, and research laboratories that will lead us into the future? We think so.

Research Laboratories 52

Research Laboratories Science Laboratories International 52

The Pharma Data

JUNE 2, 2023

Eliav Barr, senior vice president, head of global clinical development and chief medical officer, Merck Research Laboratories, said, “It is imperative that we create new ways to treat advanced cancers and help improve patient outcomes by building on the current standard of care.

FDA Approval 52

FDA Approval FDA Therapies Treatment 52

The Pharma Data

AUGUST 7, 2020

These manufactured antibodies have been developed and manufactured by Eli Lilly and Company ’s Lilly Research Laboratories in a partnership with AbCellera. The LY-CoV555 antibodies are infection fighting that can bind to the surface of viruses and prevent the virus infecting cells.

Clinical Trials 52

Clinical Trials Trials Packaging Therapies 52

Elrig

APRIL 29, 2025

Matthew Fell Executive Director of Neuroimmunology, MSD Research Laboratories Matt said Were excited to host ELRIGs first forum in the USA at our Boston facility. This June, join us for a day of groundbreaking scientific exploration with an exceptional roster of speakers, and leave inspired to push the boundaries of discovery.

Drugs 52

Drugs Science Clinical Trials Laboratories 52

Perficient: Drug Development

NOVEMBER 29, 2023

It leverages the capabilities of OpenAI, a leading artificial intelligence research laboratory, to provide access to cutting-edge models and tools. Azure OpenAI is a comprehensive cloud-based platform that enables developers to build, train, and deploy machine learning models at scale.

Research Laboratories 52

Research Laboratories Laboratories Science Research 52

The Pharma Data

MARCH 5, 2021

Loxo Oncology at Lilly was created in December 2019, combining the Lilly Research Laboratories oncology organization and Loxo Oncology, which was acquired by Lilly in early 2019. Secondary endpoints include duration of response (DOR), overall survival (OS), safety, and pharmacokinetics (PK). About Loxo Oncology at Lilly.

Clinical Trials 52

Clinical Trials Pharmacokinetics Trials Therapies 52

The Pharma Data

JUNE 1, 2022

Prior to Pfizer, Dr. Anderson worked at Merck Research Laboratories where she founded its prokaryotic bio-combinatorial engineering laboratory and initiated a bacterial vaccine program. She leaves Pfizer’s Vaccine R&D group stronger than ever and poised to continue to deliver innovative science.”.

Vaccine 40

Vaccine Research Laboratories Doctors 40

Codon

DECEMBER 10, 2023

If you have protein libraries in your research laboratory, please send them to us (datasets@alignbio.org) for analysis. The biggest challenge will be to acquire DNA that encodes millions of different proteins. Synthesizing that much DNA is cost-prohibitive. We’ll analyze the proteins and provide you with expression data for free.

Protein Expression 91

Protein Expression Laboratories DNA Engineering 91

NIH Director's Blog: Drug Development

MARCH 11, 2014

Credit: Jane Ades, National Human Genome Research Institute, NIH Type 2 diabetes (T2D) tends to run in families, and over the last five years the application of genomic technologies has led to discovery of more than 60 specific DNA variants that contribute to risk.

DNA 52

DNA Drugs Disease Research Laboratories 52

The Pharma Data

DECEMBER 17, 2020

holding positions of increasing responsibility in Merck Research Laboratories before joining the company’s executive committee as CSO. Turner currently operates his own consulting firm, MJ Turner Consulting, where he counsels biotech, pharma, venture capital and investment banking firms. He spent 27 years at Merck & Co.

Small Molecule 52

Small Molecule Clinical Development Engineering Pharmaceuticals 52

The Pharma Data

JULY 12, 2021

“Our decades-long commitment to fighting the epidemic is stronger than ever as we continue to build on our legacy of research and innovation in HIV,” said Dr. Joan Butterton, vice president, Global Clinical Development, Infectious Diseases, Merck Research Laboratories. “We

Pharmacokinetics 52

Pharmacokinetics Clinical Trials Trials Treatment 52

The Pharma Data

MARCH 13, 2021

Lilly’s chief scientific officer and president of Lilly Research Laboratories. . “We are confident in the results of the TRAILBLAZER-ALZ study,” said Daniel Skovronsky, M.D., “This is the first late-stage study in Alzheimer’s disease to meet its primary endpoint at the primary analysis.

Disease 40

Disease Trials Treatment Medical Schools 40

The Pharma Data

MARCH 30, 2021

“KEYTRUDA has become an important treatment option for certain patients with locally advanced or metastatic bladder cancer in the European Union and other countries around the world,” said Dr. Scot Ebbinghaus, vice president, clinical research, Merck Research Laboratories. “We

FDA Approval 52

FDA Approval Treatment FDA Therapies 52

The Pharma Data

SEPTEMBER 17, 2020

Lilly ‘s chief scientific officer and president of Lilly Research Laboratories. . “Based on our initial clinical studies, we believe that virus neutralizing antibodies, including LY-CoV-555, could play an important role in the fight against COVID-19,” said Daniel Skovronsky , M.D.,

Therapies 52

Therapies Production Government Disease 52

The Pharma Data

OCTOBER 19, 2020

“Pneumococcal disease in adults is on the rise globally, in part driven by disease-causing serotypes not targeted by the currently available pneumococcal conjugate vaccine,” said Dr. Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories.

Vaccine 52

Vaccine Immune Response Disease Clinical Trials 52

PPD

OCTOBER 12, 2023

Cell and gene therapies (CGTs) are one of the fastest growing areas in human therapeutics. These treatments use a vector to introduce the desired nucleic acid code to replace or modify protein expression or use cells to alter/restore a specific cell type.

Laboratories 52

Laboratories Clinical Trials Protein Expression Pharmacokinetics 52